Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis

Iron overload remains a concern in myelodysplastic syndrome (MDS) patients especially those requiring recurrent blood transfusions. Whether iron chelating therapy (ICT) is beneficial to the long-term survival of myelodysplastic syndrome is still a controversial issue. Therefore, we conducted a syste...

Ausführliche Beschreibung